Abbott Molecular Inc. recalls SARS-CoV-2 test kits due to false positives
![fda-alert-recall-compounded-drugs](/sites/default/files/styles/900x400/public/2018-04/fda-alert-recall-compounded-drugs.jpg?itok=IUogqjUy)
Abbott Molecular Inc. yesterday issued a recall for its Alinity m SARS-CoV-2 AMP Kits and Alinity m Resp-4-Plex AMP Kits, distributed between May 13, 2020, and Aug. 31, 2021, for their potential to give false positive results. The Food and Drug Administration has identified this as a Class I recall, the most serious type. FDA last month alerted clinical laboratory staff and health care providers to the potential for false positive results and recommended they consider presumptive any positive results from the tests, among other actions. Only laboratories certified to perform moderate or high complexity tests under the Clinical Laboratory Improvement Amendments can use these test kits.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…